[HTML][HTML] Prognostic and predictive biomarker developments in multiple myeloma
CT Wallington-Beddoe, RL Mynott - Journal of hematology & oncology, 2021 - Springer
New approaches to stratify multiple myeloma patients based on prognosis and therapeutic
decision-making, or prediction, are needed since patients are currently managed in a similar …
decision-making, or prediction, are needed since patients are currently managed in a similar …
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …
Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …
[HTML][HTML] Positron emission tomography (PET) in oncology
A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
Automated Whole‐Body Bone Lesion Detection for Multiple Myeloma on 68Ga‐Pentixafor PET/CT Imaging Using Deep Learning Methods
The identification of bone lesions is crucial in the diagnostic assessment of multiple
myeloma (MM). 68Ga‐Pentixafor PET/CT can capture the abnormal molecular expression of …
myeloma (MM). 68Ga‐Pentixafor PET/CT can capture the abnormal molecular expression of …
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
L Ceriani, M Martelli, PL Zinzani… - Blood, The Journal …, 2015 - ashpublications.org
Abstract The International Extranodal Lymphoma Study Group (IELSG) 26 study was
designed to evaluate the role of 18F-fluorodeoxyglucose (18FDG) positron emission …
designed to evaluate the role of 18F-fluorodeoxyglucose (18FDG) positron emission …
[HTML][HTML] PET molecular imaging: a holistic review of current practice and emerging perspectives for diagnosis, therapeutic evaluation and prognosis in clinical …
V Duclos, A Iep, L Gomez, L Goldfarb… - International journal of …, 2021 - mdpi.com
PET/CT molecular imaging has been imposed in clinical oncological practice over the past
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …
20 years, driven by its two well-grounded foundations: quantification and radiolabeled …
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)
C Nanni, A Versari, S Chauvie, E Bertone… - European journal of …, 2018 - Springer
Materials and methods Patients affected by symptomatic MM who had performed an FDG
PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) …
PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) …
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
Q Pan, X Cao, Y Luo, J Li, J Feng, F Li - European journal of nuclear …, 2020 - Springer
Abstract Purpose 18 F-FDG PET/CT has some limitations in the evaluation of multiple
myeloma (MM). Since chemokine receptor-4 is overexpressed in MM, we perform a …
myeloma (MM). Since chemokine receptor-4 is overexpressed in MM, we perform a …
Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma
JE McDonald, MM Kessler, MW Gardner, AF Buros… - Clinical Cancer …, 2017 - AACR
Purpose: Fluorine-18 fluorodeoxyglucose positron emission tomography with CT attenuation
correction (18F-FDG PET/CT) is useful in the detection and enumeration of focal lesions and …
correction (18F-FDG PET/CT) is useful in the detection and enumeration of focal lesions and …
Prognostic factors in patients treated with 223Ra: the role of skeletal tumor burden on baseline 18F-fluoride PET/CT in predicting overall survival
EC Etchebehere, JC Araujo, PS Fox… - Journal of Nuclear …, 2015 - Soc Nuclear Med
The purpose of this study was to evaluate outcome after 223Ra dichloride therapy (223Ra)
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …
and to determine whether skeletal tumor burden on whole-body 18F-fluoride PET/CT can be …